Why the study?
Does a two-phase Bayesian optimization assisted parameter learning algorithm improve glycemic regulation in an artificial pancreas simulator?
Does a two-phase Bayesian optimization assisted parameter learning algorithm improve glycemic regulation in an artificial pancreas simulator?
A novel Bayesian optimization learning algorithm for artificial pancreas systems improves simulated glycemic control without increasing hypoglycemia risk.
May support personalized AP adaptation in home settings; leaves open validation in larger randomized trials.
The long-term use of the artificial pancreas (AP) requires an automated insulin delivery algorithm that can learn and adapt with the growth, development, and lifestyle changes of patients. In this work, we introduce a data-driven AP adaptation method for improved glucose management in a home environment. A two-phase Bayesian optimization assisted parameter learning algorithm is proposed to adapt basal and carbohydrate-ratio profile, and key feedback control parameters. The method is evaluated on the basis of the 111-adult cohort of the FDA-accepted UVA/Padova type 1 diabetes mellitus simulator through three scenarios with lifestyle disturbances and incorrect initial parameters. For all the scenarios, the proposed method is able to robustly adapt AP parameters for improved glycemic regulation performance in terms of percent time in the euglycemic range [70, 180] mg/dl without causing risk of hypoglycemia in terms of percent time below 70 mg/dl.
No takes yet. Share an insight, caveat, or question.
Shi et al. (2018) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: